Nymox Pharmaceutical Corporation Cash Conversion Cycle 2011-2026 | NYMX

Annual Cash Conversion Cycle Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-2.39 K	-4.07 K	-2.85 K	-945	-1.13 K	-731

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-731	-4.07 K	-2.02 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	205	$ 16.89	-2.37 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Compugen Ltd. CGEN	-82.7	$ 2.85	-5.94 %	$ 266 M	Israel
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Coherus BioSciences CHRS	149	$ 1.58	-3.37 %	$ 185 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.46	-4.73 %	$ 204 M	Israel
Eton Pharmaceuticals ETON	115	$ 29.73	-0.77 %	$ 800 M	USA
Exelixis EXEL	-8.32	$ 50.09	-1.98 %	$ 13.6 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Fortress Biotech FBIO	-74.9	$ 2.47	7.39 %	$ 68.9 M	USA
Fennec Pharmaceuticals FENC	148	$ 9.51	2.92 %	$ 272 M	USA
AbCellera Biologics ABCL	173	$ 4.03	-8.52 %	$ 1.2 B	Canada
Autolus Therapeutics plc AUTL	119	$ 1.57	-1.26 %	$ 418 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Gilead Sciences GILD	115	$ 129.56	-1.9 %	$ 161 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Grifols, S.A. GRFS	0.000171	$ 7.67	-1.6 %	$ 5.21 B	Spain
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	-193	$ 0.72	-1.76 %	$ 32.9 M	Israel
Esperion Therapeutics ESPR	99.7	$ 3.13	0.32 %	$ 651 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	158	$ 21.66	0.42 %	$ 2.76 B	USA